Edit |   |
---|---|
Antigenic Specificity | ERBB3 & CD221, Human (Istiratumab biosimilar) |
Clone | Istiratumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa -[scFv]2 |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human ERBB3 & CD221 Recombinant Antibody. Istiratumab (MM-141) is an experimental monoclonal antibody for the treatment of cancer. It is a bispecific antibody targeting IGF-1R and ErbB3.It is in development by Merrimack Pharmaceuticals and was awarded orphan drug status for pancreatic cancer. |
Immunogen | n/a |
Other Names | Anti-ERBB3 & CD221 Recombinant Antibody, Research Grade Istiratumab, Anti-Human ERBB3 & CD221 Recombinant Antibody, MM-005, MM-141, Antibody Drug Analogues, Monoclonal Antibody, YR1370, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1509928-04-4 |
Catalog # | YR1370 |
Price | please inquire |
Order / More Info | ERBB3 & CD221, Human (Istiratumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |